Skip to main content

Table 2 Patient characteristics, IFN-γe nzyme-linked immunosorbent spot, and serum HBV DNA levels of hepatitis B surface antigen-positive children and their mothers.

From: Cellular immunity in children with successful immunoprophylactic treatment for mother-to-child transmission of hepatitis B virus

Patient ID* Age
(years)
Gender Levels of serum ALT
(IU/L)
Hepatitis B e antigen status † core 117-125
(Spots/106 PBMCs)
† pol 756-764
(Spots/106 PBMCs)
Levels of serum hepatitis B virus DNA
(copies/mL)
M9 33   18 Pos 12.6 53.9 >108.8
C9 3 Male 33 Pos 12.8 5.7 108.2
M10 47   21 Pos 12.8 30.8 108.3
C10 22 Female 30 Pos 20.7 26.2 108.6
M11 32   17 Pos 22.5 48.4 108.6
C11 4 Female 16 Pos 7.0 5.3 108.7
  1. * M and C indicate mother and child, respectively. Number indicates family ID. † More than 50 spots/106 PBMCs were defined as a significant HBV-specific T-cell response. PBMCs, peripheral blood mononuclear cells. Pos, positive Neg, negative